- Filed
- Nov 12, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Nov 10, 2021 | 100.84M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 98.38M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 88.68M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 34.35M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 34.35M sh |
| Capex | Q3 2021 · Sep 30, 2021 | $989K |
| Capex | Q3 2021 · Sep 30, 2020 | $1.72M |
| Operating Cash Flow | Q3 2021 · Sep 30, 2021 | −$28.17M |
| Operating Cash Flow restated | Q3 2021 · Sep 30, 2020 | −$11.94M |
| Cash And Equivalents | Q3 2021 · Sep 30, 2021 | $37.73M |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $38.75M |
| Cash And Equivalents restated | Q3 2021 · Sep 30, 2020 | $2.4M |
| Cash And Equivalents restated | Q3 2021 · Dec 31, 2019 | $4.54M |
| Stockholders Equity | Q3 2021 · Sep 30, 2021 | $178.21M |
| Stockholders Equity | Q3 2021 · Jun 30, 2021 | $186.17M |
| Stockholders Equity | Q3 2021 · Mar 31, 2021 | $144.25M |
| Stockholders Equity | Q3 2021 · Dec 31, 2020 | $55.07M |
| Stockholders Equity restated | Q3 2021 · Sep 30, 2020 | −$129.4M |
| Stockholders Equity restated | Q3 2021 · Jun 30, 2020 | −$118.59M |
| Stockholders Equity restated | Q3 2021 · Mar 31, 2020 | −$108.55M |
| Stockholders Equity restated | Q3 2021 · Dec 31, 2019 | −$99.94M |
| Current Liabilities | Q3 2021 · Sep 30, 2021 | $17.37M |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $15.94M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $95.41M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $29.87M |
| Current Assets | Q3 2021 · Sep 30, 2021 | $57.83M |
| Current Assets | Q3 2021 · Dec 31, 2020 | $49.08M |
| Total Assets | Q3 2021 · Sep 30, 2021 | $273.62M |
| Total Assets | Q3 2021 · Dec 31, 2020 | $84.94M |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | −$0.11 |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | −$0.43 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$0.34 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$0.89 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | −$0.11 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | −$0.43 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$0.34 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$0.89 |
| Sga Expense | Q3 2021 · Sep 30, 2021 | $21.25M |
| Sga Expense | Q3 2021 · Sep 30, 2021 | $64.99M |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $11.99M |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $30.27M |
| Net Income | Q3 2021 · Sep 30, 2021 | −$10.65M |
| Net Income | Q3 2021 · Sep 30, 2021 | −$37.7M |
| Net Income restated | Q3 2021 · Sep 30, 2020 | −$9.69M |
| Net Income restated | Q3 2021 · Sep 30, 2020 | −$25.07M |
| Operating Income | Q3 2021 · Sep 30, 2021 | −$12.81M |
| Operating Income | Q3 2021 · Sep 30, 2021 | −$40.52M |
| Operating Income restated | Q3 2021 · Sep 30, 2020 | −$6.4M |
| Operating Income restated | Q3 2021 · Sep 30, 2020 | −$16.05M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2021 | $18.56M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2021 | $45.27M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2020 | $9.53M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2020 | $29.28M |
| Revenue | Q3 2021 · Sep 30, 2021 | $26.68M |
| Revenue | Q3 2021 · Sep 30, 2021 | $66.47M |
| Revenue | Q3 2021 · Sep 30, 2020 | $15.13M |
| Revenue | Q3 2021 · Sep 30, 2020 | $43.49M |